Reason to invest in NASDAQ:NTLA and NASDAQ:BEAM Groundbreaking CRISPR Tech. Promising Treatment Pipeline. Big Pharma Partnerships. Positioned to make a significant difference in healthcare.
I am tracking Mayur Thaker's Portfolio for the next three years.
Seems like the marijuana sector might get interesting once the govt steps in.
I think gene editing stocks are finally moving
Shortage of soybean might lead to rally in the price.
Looks like a lot studies are reporting positive news, I think there is going to rally within crispr stocks.
